Global Celiac Disease Treatment Market By Celiac Disease Type(Classical Celiac Disease, Non-Classical Celiac Disease, Silent Celiac Disease, Potential celiac disease, Refractory celiac disease( Type I, Type II)) By Treatment Type (Gluten free diet, Vitamin and Mineral Supplements, Medical Therapies) By Application (Children ,Adults) By End Users( Hospitals and Clinics, Research Centers, Others) By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
Industry Trends
Celiac disease is a chronic digestive and autoimmune disorder that affects the small intestine. This means that instead of attacking infections, the immune system (white blood cells and antibodies) attacks healthy cells. Gluten-containing foods cause the condition to develop. Over the past few years, celiac disease is a cause for growing concern as the condition can lead to long-term digestive issues and prevent the body from absorbing all of the nutrients it requires. According to study, an individual is likely to develop celiac disease if someone in the family has the disease. Children and adults from all over the world are affected by celiac disease. Celiac disease is more common in white Americans than in other racial or ethnic groups in the United States. Furthermore females are more likely than males to be diagnosed with celiac disease. Additionally the gluten-free diet alone cannot keep most individuals with celiac disease healthy, nor can it completely remove the risk of serious, long-term health repercussions, according to research. Healthcare organizations are investing into research and development of drugs and supplements for effective treatment of celiac disease. Major players in the celiac disease treatment market are incorporating advanced technologies for drug development of celiac disease. Besides, the leading players in the market are collaborating and co-developing treatments and drugs for celiac disease. For instance, in September 2020, Anokion SA a biotechnology company focused on treating autoimmune disease expanded their collaboration with Bristol Myers Squibb, focused on developing therapeutics for autoimmune diseases, to include KAN-101, Anokion's primary antigen-specific therapeutic candidate for celiac disease treatment. Thus, with such advancements the celiac disease treatment market is flourishing globally.
In terms of revenue, global celiac disease treatment market was valued at US$ 462.98 Mn in 2021 growing at a CAGR of 19.78% over the forecast period (2022 – 2030). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Global Celiac Disease Treatment Market Revenue & Forecast, (US$ Million), 2015 – 2030
Celiac Disease Type Outlook
Based on the celiac disease type, the celiac disease treatment market is segmented into classical celiac disease, non-classical celiac disease, silent celiac disease, potential celiac disease, refractory celiac disease. The most common form of celiac disease appears early in childhood, with symptoms such as chronic diarrhoea, weight and energy loss, lack of appetite, illness, and bloating associated with nutritional malabsorption. It has been observed that every celiac disease type has different symptoms from each other. Thus research and various clinical trials are being carried out for development for gluten free products and medical therapies which has led to a steady growth in celiac disease treatment.
Treatment Type Outlook
Based on treatment type, the celiac disease treatment market is segmented into gluten free diet, vitamins and mineral supplements and medical therapies. Gluten free diet is considered to be an effective way for treating celiac disease. In general, most of the grains, pasta, cereals and processed foods are excluded from a gluten-free diet. A gluten-free diet is essential for monitoring the signs and symptoms of celiac disease and other gluten-related medical problems. Gluten free diet is advised commonly as by following this diet the celiac disease symptoms are being controlled and heal existing intestinal damage. Thus to cater the rising demand for gluten free products, manufacturers are developing gluten free products and supplements.
End User Outlook
Based on the end user segment, the celiac disease treatment market is segmented into hospitals and clinics, research centers and others. Hospitals and clinics have an important role to play in the diagnosis of celiac disease. Due to the rise in celiac disease, there has been a rise in diagnostic testing such as serology testing wherein the presence of certain antibodies indicate an immune reaction to gluten and genetic testing for human leukocyte antigens are provided in hospitals and clinics. Moreover hospitals and clinics are investing into better care services for celiac disease treatments such as providing them with gluten free diets and nutritionist or dietician assistance. These above factors are thus benefiting the growth of celiac disease treatment market globally.
Region Outlook
Based on the regions, North America had the highest share in the celiac disease treatment market in the year 2021. In the last few years there has been a rising prelevance of celiac disease amongst huge population. According to the study, it is estimated that 1 of 133 Americans or about 1% of the population has celiac disease in United States. There has been rise in diagnosis of celiac diseases amongst a huge population for the effective treatment. Moreover the leading players in the market are hugely investing into research and development of various medical therapies and supplements to treat celiac disease. For instance, ImmunogenX is developing latiglutenase which is a combination of two gluten-specific enzymes that breaks down gluten proteins into small, harmless fragments. The technology has been thoroughly tested in phase 1 and phase 2 clinical studies, and has been demonstrated to reduce gluten-induced intestinal mucosal injury and alleviate symptoms. Thus, with such advancements the celiac disease treatment market is experiencing steady growth across North America.
Competitive Landscape
The report provides both, qualitative and quantitative research of global celiac disease treatment market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the global celiac disease treatment market are mentioned below:
- 9 Meters Biopharma, Inc.
- Adaptive Biotechnologies
- Amgen Inc
- AMYRA Biotech AG
- BioLineRX Ltd.
- Bioniz Theraputics.
- Calypso Biotech
- CeliAct
- Gluten Free Therapeutics
- ImmunogenX, Inc.
- Inovera
- MOZART THERAPEUTICS
- Precigen, Inc.
- Takeda Pharmaceutical Company Limited
- Vactech Oy
- ZEDIRA GmbH
- Other Industry Participants.
Global Celiac Disease Treatment Market
By Celiac Disease Type
- Classical Celiac Disease
- Non-Classical Celiac Disease
- Silent Celiac Disease
- Potential celiac disease
- Refractory celiac disease
- Type I
- Type II
By Treatment Type
- Gluten free diet
- Vitamin and Mineral Supplements
- Medical Therapies
By Application
- Children
- Adults
By End Users
- Hospitals and Clinics
- Research Centers
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1.
Market
Scope
1.1. Market Segmentation
1.2. Years Considered
1.2.1. Historic Years: 2015 - 2021
1.2.2. Base Year: 2021
1.2.3. Forecast Years: 2022 – 2030
2.
Key
Target Audiences
3.
Research
Methodology
3.1. Primary Research
3.1.1. Research Questionnaire
3.1.2. Global Percentage Breakdown
3.1.3. Primary Interviews: Key Opinion Leaders
(KOLs)
3.2. Secondary Research
3.2.1. Paid Databases
3.2.2. Secondary Sources
3.3. Market Size Estimates
3.3.1. Top-Down Approach
3.3.2. Bottom-Up Approach
3.4. Data Triangulation Methodology
3.5. Research Assumptions
4.
Recommendations
and Insights from AMI’s Perspective**
5.
Holistic
Overview of Celiac Disease Treatment Market
6.
Market
Synopsis: Celiac Disease Treatment
Market
7.
Celiac
Disease Treatment Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product Definition
7.1.2. Industry Development
7.2. Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.2.4. Challenges
7.3. Trends in Celiac Disease Treatment Market
7.4. Market Determinants Radar Chart
7.5. Macro-Economic and Micro-Economic Indicators:
Celiac Disease Treatment Market
7.6. Porter’s Five Force Analysis
7.7. Impact of Covid-19 on Celiac Disease
Treatment Market
8.
Global
Celiac Disease Treatment Market Analysis and Forecasts, 2022 – 2030
8.1. Overview
8.1.1. Global Celiac Disease Treatment Market
Revenue (US$ Mn)
8.2. Global Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By Celiac Disease Type
8.2.1. Classical Celiac Disease
8.2.1.1.
Definition
8.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
8.2.1.3.
Market
Forecast, 2022 – 2030
8.2.1.4.
Compound
Annual Growth Rate (CAGR)
8.2.1.5.
Regional
Bifurcation
8.2.1.5.1.
North
America
8.2.1.5.1.1. Market Estimation, 2015 - 2021
8.2.1.5.1.2. Market Forecast, 2022 – 2030
8.2.1.5.2.
Europe
8.2.1.5.2.1. Market Estimation, 2015 - 2021
8.2.1.5.2.2. Market Forecast, 2022 – 2030
8.2.1.5.3.
Asia
Pacific
8.2.1.5.3.1. Market Estimation, 2015 - 2021
8.2.1.5.3.2. Market Forecast, 2022 – 2030
8.2.1.5.4.
Middle
East and Africa
8.2.1.5.4.1. Market Estimation, 2015 - 2021
8.2.1.5.4.2. Market Forecast, 2022 – 2030
8.2.1.5.5.
Latin
America
8.2.1.5.5.1. Market Estimation, 2015 - 2021
8.2.1.5.5.2. Market Forecast, 2022 – 2030
8.2.2. Non-Classical Celiac Disease
8.2.2.1.
Definition
8.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
8.2.2.3.
Market
Forecast, 2022 – 2030
8.2.2.4.
Compound
Annual Growth Rate (CAGR)
8.2.2.5.
Regional
Bifurcation
8.2.2.5.1.
North
America
8.2.2.5.1.1. Market Estimation, 2015 - 2021
8.2.2.5.1.2. Market Forecast, 2022 – 2030
8.2.2.5.2.
Europe
8.2.2.5.2.1. Market Estimation, 2015 - 2021
8.2.2.5.2.2. Market Forecast, 2022 – 2030
8.2.2.5.3.
Asia
Pacific
8.2.2.5.3.1. Market Estimation, 2015 - 2021
8.2.2.5.3.2. Market Forecast, 2022 – 2030
8.2.2.5.4.
Middle
East and Africa
8.2.2.5.4.1. Market Estimation, 2015 - 2021
8.2.2.5.4.2. Market Forecast, 2022 – 2030
8.2.2.5.5.
Latin
America
8.2.2.5.5.1. Market Estimation, 2015 - 2021
8.2.2.5.5.2. Market Forecast, 2022 – 2030
8.2.3. Silent Celiac Disease
8.2.3.1.
Definition
8.2.3.2.
Market
Estimation and Penetration, 2015 - 2021
8.2.3.3.
Market
Forecast, 2022 – 2030
8.2.3.4.
Compound
Annual Growth Rate (CAGR)
8.2.3.5.
Regional
Bifurcation
8.2.3.5.1.
North
America
8.2.3.5.1.1. Market Estimation, 2015 - 2021
8.2.3.5.1.2. Market Forecast, 2022 – 2030
8.2.3.5.2.
Europe
8.2.3.5.2.1. Market Estimation, 2015 - 2021
8.2.3.5.2.2. Market Forecast, 2022 – 2030
8.2.3.5.3.
Asia
Pacific
8.2.3.5.3.1. Market Estimation, 2015 - 2021
8.2.3.5.3.2. Market Forecast, 2022 – 2030
8.2.3.5.4.
Middle
East and Africa
8.2.3.5.4.1. Market Estimation, 2015 - 2021
8.2.3.5.4.2. Market Forecast, 2022 – 2030
8.2.3.5.5.
Latin
America
8.2.3.5.5.1. Market Estimation, 2015 - 2021
8.2.3.5.5.2. Market Forecast, 2022 – 2030
8.2.4. Potential celiac disease
8.2.4.1.
Definition
8.2.4.2.
Market
Estimation and Penetration, 2015 - 2021
8.2.4.3.
Market
Forecast, 2022 – 2030
8.2.4.4.
Compound
Annual Growth Rate (CAGR)
8.2.4.5.
Regional
Bifurcation
8.2.4.5.1.
North
America
8.2.4.5.1.1. Market Estimation, 2015 - 2021
8.2.4.5.1.2. Market Forecast, 2022 – 2030
8.2.4.5.2.
Europe
8.2.4.5.2.1. Market Estimation, 2015 - 2021
8.2.4.5.2.2. Market Forecast, 2022 – 2030
8.2.4.5.3.
Asia
Pacific
8.2.4.5.3.1. Market Estimation, 2015 - 2021
8.2.4.5.3.2. Market Forecast, 2022 – 2030
8.2.4.5.4.
Middle
East and Africa
8.2.4.5.4.1. Market Estimation, 2015 - 2021
8.2.4.5.4.2. Market Forecast, 2022 – 2030
8.2.4.5.5.
Latin
America
8.2.4.5.5.1. Market Estimation, 2015 - 2021
8.2.4.5.5.2. Market Forecast, 2022 – 2030
8.2.5. Refractory celiac disease (Definition, Market
Estimation and Penetration, 2015 - 2021, Market Estimation (2015 - 2021),
Market Forecast (2022 – 2030), Compound Annual Growth Rate (CAGR), Regional
Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin
America) and Information on Type I, Type
II)
8.2.5.1.
Type I
8.2.5.2.
Type II
8.3. Key Segment for Channeling Investments
8.3.1. By Celiac Disease Type
9.
Global
Celiac Disease Treatment Market Analysis and Forecasts, 2022 – 2030
9.1. Overview
9.2. Global Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By Treatment Type
9.2.1. Gluten free diet
9.2.1.1.
Definition
9.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.1.3.
Market
Forecast, 2022 – 2030
9.2.1.4.
Compound
Annual Growth Rate (CAGR)
9.2.1.5.
Regional
Bifurcation
9.2.1.5.1.
North
America
9.2.1.5.1.1. Market Estimation, 2015 - 2021
9.2.1.5.1.2. Market Forecast, 2022 – 2030
9.2.1.5.2.
Europe
9.2.1.5.2.1. Market Estimation, 2015 - 2021
9.2.1.5.2.2. Market Forecast, 2022 – 2030
9.2.1.5.3.
Asia
Pacific
9.2.1.5.3.1. Market Estimation, 2015 - 2021
9.2.1.5.3.2. Market Forecast, 2022 – 2030
9.2.1.5.4.
Middle
East and Africa
9.2.1.5.4.1. Market Estimation, 2015 - 2021
9.2.1.5.4.2. Market Forecast, 2022 – 2030
9.2.1.5.5.
Latin
America
9.2.1.5.5.1. Market Estimation, 2015 - 2021
9.2.1.5.5.2. Market Forecast, 2022 – 2030
9.2.2. Vitamin and Mineral Supplements
9.2.2.1.
Definition
9.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.2.3.
Market
Forecast, 2022 – 2030
9.2.2.4.
Compound
Annual Growth Rate (CAGR)
9.2.2.5.
Regional
Bifurcation
9.2.2.5.1.
North
America
9.2.2.5.1.1. Market Estimation, 2015 - 2021
9.2.2.5.1.2. Market Forecast, 2022 – 2030
9.2.2.5.2.
Europe
9.2.2.5.2.1. Market Estimation, 2015 - 2021
9.2.2.5.2.2. Market Forecast, 2022 – 2030
9.2.2.5.3.
Asia
Pacific
9.2.2.5.3.1. Market Estimation, 2015 - 2021
9.2.2.5.3.2. Market Forecast, 2022 – 2030
9.2.2.5.4.
Middle
East and Africa
9.2.2.5.4.1. Market Estimation, 2015 - 2021
9.2.2.5.4.2. Market Forecast, 2022 – 2030
9.2.2.5.5.
Latin
America
9.2.2.5.5.1. Market Estimation, 2015 - 2021
9.2.2.5.5.2. Market Forecast, 2022 – 2030
9.2.3. Medical Therapies
9.2.3.1.
Definition
9.2.3.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.3.3.
Market
Forecast, 2022 – 2030
9.2.3.4.
Compound
Annual Growth Rate (CAGR)
9.2.3.5.
Regional
Bifurcation
9.2.3.5.1.
North
America
9.2.3.5.1.1. Market Estimation, 2015 - 2021
9.2.3.5.1.2. Market Forecast, 2022 – 2030
9.2.3.5.2.
Europe
9.2.3.5.2.1. Market Estimation, 2015 - 2021
9.2.3.5.2.2. Market Forecast, 2022 – 2030
9.2.3.5.3.
Asia
Pacific
9.2.3.5.3.1. Market Estimation, 2015 - 2021
9.2.3.5.3.2. Market Forecast, 2022 – 2030
9.2.3.5.4.
Middle
East and Africa
9.2.3.5.4.1. Market Estimation, 2015 - 2021
9.2.3.5.4.2. Market Forecast, 2022 – 2030
9.2.3.5.5.
Latin
America
9.2.3.5.5.1. Market Estimation, 2015 - 2021
9.2.3.5.5.2. Market Forecast, 2022 – 2030
9.3. Key Segment for Channeling Investments
9.3.1. By Treatment Type
10. Global Celiac Disease Treatment Market
Analysis and Forecasts, 2022 – 2030
10.1. Overview
10.2. Global Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By
Application
10.2.1. Children
10.2.1.1. Definition
10.2.1.2. Market Estimation and Penetration, 2015 -
2021
10.2.1.3. Market Forecast, 2022 – 2030
10.2.1.4. Compound Annual Growth Rate (CAGR)
10.2.1.5. Regional Bifurcation
10.2.1.5.1. North America
10.2.1.5.1.1. Market Estimation, 2015 - 2021
10.2.1.5.1.2. Market Forecast, 2022 – 2030
10.2.1.5.2. Europe
10.2.1.5.2.1. Market Estimation, 2015 - 2021
10.2.1.5.2.2. Market Forecast, 2022 – 2030
10.2.1.5.3. Asia Pacific
10.2.1.5.3.1. Market Estimation, 2015 - 2021
10.2.1.5.3.2. Market Forecast, 2022 – 2030
10.2.1.5.4. Middle East and Africa
10.2.1.5.4.1. Market Estimation, 2015 - 2021
10.2.1.5.4.2. Market Forecast, 2022 – 2030
10.2.1.5.5. Latin America
10.2.1.5.5.1. Market Estimation, 2015 - 2021
10.2.1.5.5.2. Market Forecast, 2022 – 2030
10.2.2. Adults
10.2.2.1. Definition
10.2.2.2. Market Estimation and Penetration, 2015 -
2021
10.2.2.3. Market Forecast, 2022 – 2030
10.2.2.4. Compound Annual Growth Rate (CAGR)
10.2.2.5. Regional Bifurcation
10.2.2.5.1. North America
10.2.2.5.1.1. Market Estimation, 2015 - 2021
10.2.2.5.1.2. Market Forecast, 2022 – 2030
10.2.2.5.2. Europe
10.2.2.5.2.1. Market Estimation, 2015 - 2021
10.2.2.5.2.2. Market Forecast, 2022 – 2030
10.2.2.5.3. Asia Pacific
10.2.2.5.3.1. Market Estimation, 2015 - 2021
10.2.2.5.3.2. Market Forecast, 2022 – 2030
10.2.2.5.4. Middle East and Africa
10.2.2.5.4.1. Market Estimation, 2015 - 2021
10.2.2.5.4.2. Market Forecast, 2022 – 2030
10.2.2.5.5. Latin America
10.2.2.5.5.1. Market Estimation, 2015 - 2021
10.2.2.5.5.2. Market Forecast, 2022 – 2030
10.3. Key Segment for Channeling Investments
10.3.1. By
Application
11. Global Celiac Disease Treatment Market
Analysis and Forecasts, 2022 – 2030
11.1. Overview
11.2. Global Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By End Users
11.2.1. Hospitals and Clinics
11.2.1.1. Definition
11.2.1.2. Market Estimation and Penetration, 2015 -
2021
11.2.1.3. Market Forecast, 2022 – 2030
11.2.1.4. Compound Annual Growth Rate (CAGR)
11.2.1.5. Regional Bifurcation
11.2.1.5.1. North America
11.2.1.5.1.1. Market Estimation, 2015 - 2021
11.2.1.5.1.2. Market Forecast, 2022 – 2030
11.2.1.5.2. Europe
11.2.1.5.2.1. Market Estimation, 2015 - 2021
11.2.1.5.2.2. Market Forecast, 2022 – 2030
11.2.1.5.3. Asia Pacific
11.2.1.5.3.1. Market Estimation, 2015 - 2021
11.2.1.5.3.2. Market Forecast, 2022 – 2030
11.2.1.5.4. Middle East and Africa
11.2.1.5.4.1. Market Estimation, 2015 - 2021
11.2.1.5.4.2. Market Forecast, 2022 – 2030
11.2.1.5.5. Latin America
11.2.1.5.5.1. Market Estimation, 2015 - 2021
11.2.1.5.5.2. Market Forecast, 2022 – 2030
11.2.2. Research Centers
11.2.2.1. Definition
11.2.2.2. Market Estimation and Penetration, 2015 -
2021
11.2.2.3. Market Forecast, 2022 – 2030
11.2.2.4. Compound Annual Growth Rate (CAGR)
11.2.2.5. Regional Bifurcation
11.2.2.5.1. North America
11.2.2.5.1.1. Market Estimation, 2015 - 2021
11.2.2.5.1.2. Market Forecast, 2022 – 2030
11.2.2.5.2. Europe
11.2.2.5.2.1. Market Estimation, 2015 - 2021
11.2.2.5.2.2. Market Forecast, 2022 – 2030
11.2.2.5.3. Asia Pacific
11.2.2.5.3.1. Market Estimation, 2015 - 2021
11.2.2.5.3.2. Market Forecast, 2022 – 2030
11.2.2.5.4. Middle East and Africa
11.2.2.5.4.1. Market Estimation, 2015 - 2021
11.2.2.5.4.2. Market Forecast, 2022 – 2030
11.2.2.5.5. Latin America
11.2.2.5.5.1. Market Estimation, 2015 - 2021
11.2.2.5.5.2. Market Forecast, 2022 – 2030
11.2.3. Others
11.2.3.1. Definition
11.2.3.2. Market Estimation and Penetration, 2015 -
2021
11.2.3.3. Market Forecast, 2022 – 2030
11.2.3.4. Compound Annual Growth Rate (CAGR)
11.2.3.5. Regional Bifurcation
11.2.3.5.1. North America
11.2.3.5.1.1. Market Estimation, 2015 - 2021
11.2.3.5.1.2. Market Forecast, 2022 – 2030
11.2.3.5.2. Europe
11.2.3.5.2.1. Market Estimation, 2015 - 2021
11.2.3.5.2.2. Market Forecast, 2022 – 2030
11.2.3.5.3. Asia Pacific
11.2.3.5.3.1. Market Estimation, 2015 - 2021
11.2.3.5.3.2. Market Forecast, 2022 – 2030
11.2.3.5.4. Middle East and Africa
11.2.3.5.4.1. Market Estimation, 2015 - 2021
11.2.3.5.4.2. Market Forecast, 2022 – 2030
11.2.3.5.5. Latin America
11.2.3.5.5.1. Market Estimation, 2015 - 2021
11.2.3.5.5.2. Market Forecast, 2022 – 2030
11.3. Key Segment for Channeling Investments
11.3.1. By End Users
12. North America Celiac Disease Treatment
Market Analysis and Forecasts, 2022 – 2030
12.1. Overview
12.1.1. North America Celiac Disease Treatment Market
Revenue (US$ Mn)
12.2. North America Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By Celiac Disease Type
12.2.1. Classical Celiac Disease
12.2.2. Non-Classical Celiac Disease
12.2.3. Silent Celiac Disease
12.2.4. Potential celiac disease
12.2.5. Refractory celiac disease
12.2.5.1. Type I
12.2.5.2. Type
II
12.3. North America Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By Treatment Type
12.3.1. Gluten free diet
12.3.2. Vitamin and Mineral Supplements
12.3.3. Medical Therapies
12.4. North America Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By
Application
12.4.1. Children
12.4.2. Adults
12.5. North America Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By End Users
12.5.1. Hospitals and Clinics
12.5.2. Research Centers
12.5.3. Others
12.6. North America Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By Country
12.6.1. U.S
12.6.1.1. U.S Celiac Disease Treatment Market Revenue
(US$ Mn) and Forecasts, By Celiac Disease Type
12.6.1.1.1. Classical Celiac Disease
12.6.1.1.2. Non-Classical Celiac Disease
12.6.1.1.3. Silent Celiac Disease
12.6.1.1.4. Potential celiac disease
12.6.1.1.5. Refractory celiac disease
12.6.1.1.5.1. Type I
12.6.1.1.5.2. Type
II
12.6.1.2. U.S Celiac Disease Treatment Market Revenue (US$
Mn) and Forecasts, By Treatment Type
12.6.1.2.1. Gluten free diet
12.6.1.2.2. Vitamin and Mineral Supplements
12.6.1.2.3. Medical Therapies
12.6.1.3. U.S Celiac Disease Treatment Market Revenue
(US$ Mn) and Forecasts, By Application
12.6.1.3.1. Children
12.6.1.3.2. Adults
12.6.1.4. U.S Celiac Disease Treatment Market Revenue (US$
Mn) and Forecasts, By End Users
12.6.1.4.1. Hospitals and Clinics
12.6.1.4.2. Research Centers
12.6.1.4.3. Others
12.6.2. Canada
12.6.2.1. Canada Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By Celiac Disease Type
12.6.2.1.1. Classical Celiac Disease
12.6.2.1.2. Non-Classical Celiac Disease
12.6.2.1.3. Silent Celiac Disease
12.6.2.1.4. Potential celiac disease
12.6.2.1.5. Refractory celiac disease
12.6.2.1.5.1. Type I
12.6.2.1.5.2. Type
II
12.6.2.2. Canada Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By Treatment Type
12.6.2.2.1. Gluten free diet
12.6.2.2.2. Vitamin and Mineral Supplements
12.6.2.2.3. Medical Therapies
12.6.2.3. Canada Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By
Application
12.6.2.3.1. Children
12.6.2.3.2. Adults
12.6.2.4. Canada Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By End Users
12.6.2.4.1. Hospitals and Clinics
12.6.2.4.2. Research Centers
12.6.2.4.3. Others
12.6.3. Mexico
12.6.3.1. Mexico Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By Celiac Disease Type
12.6.3.1.1. Classical Celiac Disease
12.6.3.1.2. Non-Classical Celiac Disease
12.6.3.1.3. Silent Celiac Disease
12.6.3.1.4. Potential celiac disease
12.6.3.1.5. Refractory celiac disease
12.6.3.1.5.1. Type I
12.6.3.1.5.2. Type
II
12.6.3.2. Mexico Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By Treatment Type
12.6.3.2.1. Gluten free diet
12.6.3.2.2. Vitamin and Mineral Supplements
12.6.3.2.3. Medical Therapies
12.6.3.3. Mexico Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By
Application
12.6.3.3.1. Children
12.6.3.3.2. Adults
12.6.3.4. Mexico Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By End Users
12.6.3.4.1. Hospitals and Clinics
12.6.3.4.2. Research Centers
12.6.3.4.3. Others
12.6.4. Rest of North America
12.6.4.1. Rest of North America Celiac Disease
Treatment Market Revenue (US$ Mn) and Forecasts, By Celiac Disease Type
12.6.4.1.1. Classical Celiac Disease
12.6.4.1.2. Non-Classical Celiac Disease
12.6.4.1.3. Silent Celiac Disease
12.6.4.1.4. Potential celiac disease
12.6.4.1.5. Refractory celiac disease
12.6.4.1.5.1. Type I
12.6.4.1.5.2. Type
II
12.6.4.2. Rest of North America Celiac Disease
Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment Type
12.6.4.2.1. Gluten free diet
12.6.4.2.2. Vitamin and Mineral Supplements
12.6.4.2.3. Medical Therapies
12.6.4.3. Rest of North America Celiac Disease
Treatment Market Revenue (US$ Mn) and Forecasts, By Application
12.6.4.3.1. Children
12.6.4.3.2. Adults
12.6.4.4. Rest of North America Celiac Disease
Treatment Market Revenue (US$ Mn) and Forecasts, By End Users
12.6.4.4.1. Hospitals and Clinics
12.6.4.4.2. Research Centers
12.6.4.4.3. Others
12.7. Key Segment for Channeling Investments
12.7.1. By Country
12.7.2. By Celiac Disease Type
12.7.3. By Treatment Type
12.7.4. By
Application
12.7.5. By End Users
13. Europe Celiac Disease Treatment Market
Analysis and Forecasts, 2022 – 2030
13.1. Overview
13.1.1. Europe Celiac Disease Treatment Market
Revenue (US$ Mn)
13.2. Europe Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By Celiac Disease Type
13.2.1. Classical Celiac Disease
13.2.2. Non-Classical Celiac Disease
13.2.3. Silent Celiac Disease
13.2.4. Potential celiac disease
13.2.5. Refractory celiac disease
13.2.5.1. Type I
13.2.5.2. Type
II
13.3. Europe Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By Treatment Type
13.3.1. Gluten free diet
13.3.2. Vitamin and Mineral Supplements
13.3.3. Medical Therapies
13.4. Europe Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By
Application
13.4.1. Children
13.4.2. Adults
13.5. Europe Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By End Users
13.5.1. Hospitals and Clinics
13.5.2. Research Centers
13.5.3. Others
13.6. Europe Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By Country
13.6.1. France
13.6.1.1. France Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By Celiac Disease Type
13.6.1.1.1. Classical Celiac Disease
13.6.1.1.2. Non-Classical Celiac Disease
13.6.1.1.3. Silent Celiac Disease
13.6.1.1.4. Potential celiac disease
13.6.1.1.5. Refractory celiac disease
13.6.1.1.5.1. Type I
13.6.1.1.5.2. Type
II
13.6.1.2. France Celiac Disease Treatment Market Revenue
(US$ Mn) and Forecasts, By Treatment Type
13.6.1.2.1. Gluten free diet
13.6.1.2.2. Vitamin and Mineral Supplements
13.6.1.2.3. Medical Therapies
13.6.1.3. France Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By
Application
13.6.1.3.1. Children
13.6.1.3.2. Adults
13.6.1.4. France Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By End Users
13.6.1.4.1. Hospitals and Clinics
13.6.1.4.2. Research Centers
13.6.1.4.3. Others
13.6.2. The UK
13.6.2.1. The UK Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By Celiac Disease Type
13.6.2.1.1. Classical Celiac Disease
13.6.2.1.2. Non-Classical Celiac Disease
13.6.2.1.3. Silent Celiac Disease
13.6.2.1.4. Potential celiac disease
13.6.2.1.5. Refractory celiac disease
13.6.2.1.5.1. Type I
13.6.2.1.5.2. Type
II
13.6.2.2. The UK Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By Treatment Type
13.6.2.2.1. Gluten free diet
13.6.2.2.2. Vitamin and Mineral Supplements
13.6.2.2.3. Medical Therapies
13.6.2.3. The UK Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By
Application
13.6.2.3.1. Children
13.6.2.3.2. Adults
13.6.2.4. The UK Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By End Users
13.6.2.4.1. Hospitals and Clinics
13.6.2.4.2. Research Centers
13.6.2.4.3. Others
13.6.3. Spain
13.6.3.1. Spain Celiac Disease Treatment Market Revenue
(US$ Mn) and Forecasts, By Celiac Disease Type
13.6.3.1.1. Classical Celiac Disease
13.6.3.1.2. Non-Classical Celiac Disease
13.6.3.1.3. Silent Celiac Disease
13.6.3.1.4. Potential celiac disease
13.6.3.1.5. Refractory celiac disease
13.6.3.1.5.1. Type I
13.6.3.1.5.2. Type
II
13.6.3.2. Spain Celiac Disease Treatment Market Revenue
(US$ Mn) and Forecasts, By Treatment Type
13.6.3.2.1. Gluten free diet
13.6.3.2.2. Vitamin and Mineral Supplements
13.6.3.2.3. Medical Therapies
13.6.3.3. Spain Celiac Disease Treatment Market Revenue
(US$ Mn) and Forecasts, By Application
13.6.3.3.1. Children
13.6.3.3.2. Adults
13.6.3.4. Spain Celiac Disease Treatment Market Revenue
(US$ Mn) and Forecasts, By End Users
13.6.3.4.1. Hospitals and Clinics
13.6.3.4.2. Research Centers
13.6.3.4.3. Others
13.6.4. Germany
13.6.4.1. Germany Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By Celiac Disease Type
13.6.4.1.1. Classical Celiac Disease
13.6.4.1.2. Non-Classical Celiac Disease
13.6.4.1.3. Silent Celiac Disease
13.6.4.1.4. Potential celiac disease
13.6.4.1.5. Refractory celiac disease
13.6.4.1.5.1. Type I
13.6.4.1.5.2. Type
II
13.6.4.2. Germany Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By Treatment Type
13.6.4.2.1. Gluten free diet
13.6.4.2.2. Vitamin and Mineral Supplements
13.6.4.2.3. Medical Therapies
13.6.4.3. Germany Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By
Application
13.6.4.3.1. Children
13.6.4.3.2. Adults
13.6.4.4. Germany Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By End Users
13.6.4.4.1. Hospitals and Clinics
13.6.4.4.2. Research Centers
13.6.4.4.3. Others
13.6.5. Italy
13.6.5.1. Italy Celiac Disease Treatment Market Revenue
(US$ Mn) and Forecasts, By Celiac Disease Type
13.6.5.1.1. Classical Celiac Disease
13.6.5.1.2. Non-Classical Celiac Disease
13.6.5.1.3. Silent Celiac Disease
13.6.5.1.4. Potential celiac disease
13.6.5.1.5. Refractory celiac disease
13.6.5.1.5.1. Type I
13.6.5.1.5.2. Type
II
13.6.5.2. Italy Celiac Disease Treatment Market Revenue
(US$ Mn) and Forecasts, By Treatment Type
13.6.5.2.1. Gluten free diet
13.6.5.2.2. Vitamin and Mineral Supplements
13.6.5.2.3. Medical Therapies
13.6.5.3. Italy Celiac Disease Treatment Market Revenue
(US$ Mn) and Forecasts, By Application
13.6.5.3.1. Children
13.6.5.3.2. Adults
13.6.5.4. Italy Celiac Disease Treatment Market Revenue
(US$ Mn) and Forecasts, By End Users
13.6.5.4.1. Hospitals and Clinics
13.6.5.4.2. Research Centers
13.6.5.4.3. Others
13.6.6. Nordic Countries
13.6.6.1. Nordic Countries Celiac Disease Treatment
Market Revenue (US$ Mn) and Forecasts, By Celiac Disease Type
13.6.6.1.1. Classical Celiac Disease
13.6.6.1.2. Non-Classical Celiac Disease
13.6.6.1.3. Silent Celiac Disease
13.6.6.1.4. Potential celiac disease
13.6.6.1.5. Refractory celiac disease
13.6.6.1.5.1. Type I
13.6.6.1.5.2. Type
II
13.6.6.2. Nordic Countries Celiac Disease Treatment
Market Revenue (US$ Mn) and Forecasts, By Treatment Type
13.6.6.2.1. Gluten free diet
13.6.6.2.2. Vitamin and Mineral Supplements
13.6.6.2.3. Medical Therapies
13.6.6.3. Nordic Countries Celiac Disease Treatment
Market Revenue (US$ Mn) and Forecasts, By
Application
13.6.6.3.1. Children
13.6.6.3.2. Adults
13.6.6.4. Nordic Countries Celiac Disease Treatment
Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.6.4.1. Hospitals and Clinics
13.6.6.4.2. Research Centers
13.6.6.4.3. Others
13.6.6.5. Nordic Countries Celiac Disease Treatment
Market Revenue (US$ Mn) and Forecasts, By Country
13.6.6.5.1. Denmark
13.6.6.5.2. Finland
13.6.6.5.3. Iceland
13.6.6.5.4. Sweden
13.6.6.5.5. Norway
13.6.7. Benelux Union
13.6.7.1. Benelux Union Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By Celiac Disease Type
13.6.7.1.1. Classical Celiac Disease
13.6.7.1.2. Non-Classical Celiac Disease
13.6.7.1.3. Silent Celiac Disease
13.6.7.1.4. Potential celiac disease
13.6.7.1.5. Refractory celiac disease
13.6.7.1.5.1. Type I
13.6.7.1.5.2. Type
II
13.6.7.2. Benelux Union Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By Treatment Type
13.6.7.2.1. Gluten free diet
13.6.7.2.2. Vitamin and Mineral Supplements
13.6.7.2.3. Medical Therapies
13.6.7.3. Benelux Union Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By
Application
13.6.7.3.1. Children
13.6.7.3.2. Adults
13.6.7.4. Benelux Union Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By End Users
13.6.7.4.1. Hospitals and Clinics
13.6.7.4.2. Research Centers
13.6.7.4.3. Others
13.6.7.5. Benelux Union Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By Country
13.6.7.5.1. Belgium
13.6.7.5.2. The Netherlands
13.6.7.5.3. Luxembourg
13.6.8. Rest of Europe
13.6.8.1. Rest of Europe Celiac Disease Treatment
Market Revenue (US$ Mn) and Forecasts, By Celiac Disease Type
13.6.8.1.1. Classical Celiac Disease
13.6.8.1.2. Non-Classical Celiac Disease
13.6.8.1.3. Silent Celiac Disease
13.6.8.1.4. Potential celiac disease
13.6.8.1.5. Refractory celiac disease
13.6.8.1.5.1. Type I
13.6.8.1.5.2. Type
II
13.6.8.2. Rest of Europe Celiac Disease Treatment
Market Revenue (US$ Mn) and Forecasts, By Treatment Type
13.6.8.2.1. Gluten free diet
13.6.8.2.2. Vitamin and Mineral Supplements
13.6.8.2.3. Medical Therapies
13.6.8.3. Rest of Europe Celiac Disease Treatment
Market Revenue (US$ Mn) and Forecasts, By
Application
13.6.8.3.1. Children
13.6.8.3.2. Adults
13.6.8.4. Rest of Europe Celiac Disease Treatment
Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.8.4.1. Hospitals and Clinics
13.6.8.4.2. Research Centers
13.6.8.4.3. Others
13.7. Key Segment for Channeling Investments
13.7.1. By Country
13.7.2. By Celiac Disease Type
13.7.3. By Treatment Type
13.7.4. By
Application
13.7.5. By End Users
14. Asia Pacific Celiac Disease Treatment Market
Analysis and Forecasts, 2022 – 2030
14.1. Overview
14.1.1. Asia Pacific Celiac Disease Treatment Market
Revenue (US$ Mn)
14.2. Asia Pacific Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By Celiac Disease Type
14.2.1. Classical Celiac Disease
14.2.2. Non-Classical Celiac Disease
14.2.3. Silent Celiac Disease
14.2.4. Potential celiac disease
14.2.5. Refractory celiac disease
14.2.5.1. Type I
14.2.5.2. Type
II
14.3. Asia Pacific Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By Treatment Type
14.3.1. Gluten free diet
14.3.2. Vitamin and Mineral Supplements
14.3.3. Medical Therapies
14.4. Asia Pacific Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By
Application
14.4.1. Children
14.4.2. Adults
14.5. Asia Pacific Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By End Users
14.5.1. Hospitals and Clinics
14.5.2. Research Centers
14.5.3. Others
14.6. Asia Pacific Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By Country
14.6.1. China
14.6.1.1. China Celiac Disease Treatment Market Revenue
(US$ Mn) and Forecasts, By Celiac Disease Type
14.6.1.1.1. Classical Celiac Disease
14.6.1.1.2. Non-Classical Celiac Disease
14.6.1.1.3. Silent Celiac Disease
14.6.1.1.4. Potential celiac disease
14.6.1.1.5. Refractory celiac disease
14.6.1.1.5.1. Type I
14.6.1.1.5.2. Type
II
14.6.1.2. China Celiac Disease Treatment Market Revenue
(US$ Mn) and Forecasts, By Treatment Type
14.6.1.2.1. Gluten free diet
14.6.1.2.2. Vitamin and Mineral Supplements
14.6.1.2.3. Medical Therapies
14.6.1.3. China Celiac Disease Treatment Market Revenue
(US$ Mn) and Forecasts, By Application
14.6.1.3.1. Children
14.6.1.3.2. Adults
14.6.1.4. China Celiac Disease Treatment Market Revenue
(US$ Mn) and Forecasts, By End Users
14.6.1.4.1. Hospitals and Clinics
14.6.1.4.2. Research Centers
14.6.1.4.3. Others
14.6.2. Japan
14.6.2.1. Japan Celiac Disease Treatment Market Revenue
(US$ Mn) and Forecasts, By Celiac Disease Type
14.6.2.1.1. Classical Celiac Disease
14.6.2.1.2. Non-Classical Celiac Disease
14.6.2.1.3. Silent Celiac Disease
14.6.2.1.4. Potential celiac disease
14.6.2.1.5. Refractory celiac disease
14.6.2.1.5.1. Type I
14.6.2.1.5.2. Type
II
14.6.2.2. Japan Celiac Disease Treatment Market Revenue
(US$ Mn) and Forecasts, By Treatment Type
14.6.2.2.1. Gluten free diet
14.6.2.2.2. Vitamin and Mineral Supplements
14.6.2.2.3. Medical Therapies
14.6.2.3. Japan Celiac Disease Treatment Market Revenue
(US$ Mn) and Forecasts, By Application
14.6.2.3.1. Children
14.6.2.3.2. Adults
14.6.2.4. Japan Celiac Disease Treatment Market Revenue
(US$ Mn) and Forecasts, By End Users
14.6.2.4.1. Hospitals and Clinics
14.6.2.4.2. Research Centers
14.6.2.4.3. Others
14.6.3. India
14.6.3.1. India Celiac Disease Treatment Market Revenue
(US$ Mn) and Forecasts, By Celiac Disease Type
14.6.3.1.1. Classical Celiac Disease
14.6.3.1.2. Non-Classical Celiac Disease
14.6.3.1.3. Silent Celiac Disease
14.6.3.1.4. Potential celiac disease
14.6.3.1.5. Refractory celiac disease
14.6.3.1.5.1. Type I
14.6.3.1.5.2. Type
II
14.6.3.2. India Celiac Disease Treatment Market Revenue
(US$ Mn) and Forecasts, By Treatment Type
14.6.3.2.1. Gluten free diet
14.6.3.2.2. Vitamin and Mineral Supplements
14.6.3.2.3. Medical Therapies
14.6.3.3. India Celiac Disease Treatment Market Revenue
(US$ Mn) and Forecasts, By Application
14.6.3.3.1. Children
14.6.3.3.2. Adults
14.6.3.4. India Celiac Disease Treatment Market Revenue
(US$ Mn) and Forecasts, By End Users
14.6.3.4.1. Hospitals and Clinics
14.6.3.4.2. Research Centers
14.6.3.4.3. Others
14.6.4. New Zealand
14.6.4.1. New Zealand Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By Celiac Disease Type
14.6.4.1.1. Classical Celiac Disease
14.6.4.1.2. Non-Classical Celiac Disease
14.6.4.1.3. Silent Celiac Disease
14.6.4.1.4. Potential celiac disease
14.6.4.1.5. Refractory celiac disease
14.6.4.1.5.1. Type I
14.6.4.1.5.2. Type
II
14.6.4.2. New Zealand Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By Treatment Type
14.6.4.2.1. Gluten free diet
14.6.4.2.2. Vitamin and Mineral Supplements
14.6.4.2.3. Medical Therapies
14.6.4.3. New Zealand Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By
Application
14.6.4.3.1. Children
14.6.4.3.2. Adults
14.6.4.4. New Zealand Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By End Users
14.6.4.4.1. Hospitals and Clinics
14.6.4.4.2. Research Centers
14.6.4.4.3. Others
14.6.5. Australia
14.6.5.1. Australia Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By Celiac Disease Type
14.6.5.1.1. Classical Celiac Disease
14.6.5.1.2. Non-Classical Celiac Disease
14.6.5.1.3. Silent Celiac Disease
14.6.5.1.4. Potential celiac disease
14.6.5.1.5. Refractory celiac disease
14.6.5.1.5.1. Type I
14.6.5.1.5.2. Type
II
14.6.5.2. Australia Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By Treatment Type
14.6.5.2.1. Gluten free diet
14.6.5.2.2. Vitamin and Mineral Supplements
14.6.5.2.3. Medical Therapies
14.6.5.3. Australia Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By
Application
14.6.5.3.1. Children
14.6.5.3.2. Adults
14.6.5.4. Australia Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By End Users
14.6.5.4.1. Hospitals and Clinics
14.6.5.4.2. Research Centers
14.6.5.4.3. Others
14.6.6. South Korea
14.6.6.1. South Korea Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By Celiac Disease Type
14.6.6.1.1. Classical Celiac Disease
14.6.6.1.2. Non-Classical Celiac Disease
14.6.6.1.3. Silent Celiac Disease
14.6.6.1.4. Potential celiac disease
14.6.6.1.5. Refractory celiac disease
14.6.6.1.5.1. Type I
14.6.6.1.5.2. Type
II
14.6.6.2. South Korea Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By Treatment Type
14.6.6.2.1. Gluten free diet
14.6.6.2.2. Vitamin and Mineral Supplements
14.6.6.2.3. Medical Therapies
14.6.6.3. South Korea Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By
Application
14.6.6.3.1. Children
14.6.6.3.2. Adults
14.6.6.4. South Korea Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By End Users
14.6.6.4.1. Hospitals and Clinics
14.6.6.4.2. Research Centers
14.6.6.4.3. Others
14.6.7. Southeast Asia
14.6.7.1. Southeast Asia Celiac Disease Treatment
Market Revenue (US$ Mn) and Forecasts, By Celiac Disease Type
14.6.7.1.1. Classical Celiac Disease
14.6.7.1.2. Non-Classical Celiac Disease
14.6.7.1.3. Silent Celiac Disease
14.6.7.1.4. Potential celiac disease
14.6.7.1.5. Refractory celiac disease
14.6.7.1.5.1. Type I
14.6.7.1.5.2. Type
II
14.6.7.2. Southeast Asia Celiac Disease Treatment
Market Revenue (US$ Mn) and Forecasts, By Treatment Type
14.6.7.2.1. Gluten free diet
14.6.7.2.2. Vitamin and Mineral Supplements
14.6.7.2.3. Medical Therapies
14.6.7.3. Southeast Asia Celiac Disease Treatment
Market Revenue (US$ Mn) and Forecasts, By
Application
14.6.7.3.1. Children
14.6.7.3.2. Adults
14.6.7.4. Southeast Asia Celiac Disease Treatment
Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.7.4.1. Hospitals and Clinics
14.6.7.4.2. Research Centers
14.6.7.4.3. Others
14.6.7.5. Southeast Asia Celiac Disease Treatment
Market Revenue (US$ Mn) and Forecasts, By Country
14.6.7.5.1. Indonesia
14.6.7.5.2. Thailand
14.6.7.5.3. Malaysia
14.6.7.5.4. Singapore
14.6.7.5.5. Rest of Southeast Asia
14.6.8. Rest of Asia Pacific
14.6.8.1. Rest of Asia Pacific Celiac Disease Treatment
Market Revenue (US$ Mn) and Forecasts, By Celiac Disease Type
14.6.8.1.1. Classical Celiac Disease
14.6.8.1.2. Non-Classical Celiac Disease
14.6.8.1.3. Silent Celiac Disease
14.6.8.1.4. Potential celiac disease
14.6.8.1.5. Refractory celiac disease
14.6.8.1.5.1. Type I
14.6.8.1.5.2. Type
II
14.6.8.2. Rest of Asia Pacific Celiac Disease Treatment
Market Revenue (US$ Mn) and Forecasts, By Treatment Type
14.6.8.2.1. Gluten free diet
14.6.8.2.2. Vitamin and Mineral Supplements
14.6.8.2.3. Medical Therapies
14.6.8.3. Rest of Asia Pacific Celiac Disease Treatment
Market Revenue (US$ Mn) and Forecasts, By
Application
14.6.8.3.1. Children
14.6.8.3.2. Adults
14.6.8.4. Rest of Asia Pacific Celiac Disease Treatment
Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.8.4.1. Hospitals and Clinics
14.6.8.4.2. Research Centers
14.6.8.4.3. Others
14.7. Key Segment for Channeling Investments
14.7.1. By Country
14.7.2. By Celiac Disease Type
14.7.3. By Treatment Type
14.7.4. By Application
14.7.5. By End Users
15. Middle East and Africa Celiac Disease
Treatment Market Analysis and Forecasts, 2022 – 2030
15.1. Overview
15.1.1. Middle East and Africa Celiac Disease
Treatment Market Revenue (US$ Mn)
15.2. Middle East and Africa Celiac Disease
Treatment Market Revenue (US$ Mn) and Forecasts, By Celiac Disease Type
15.2.1. Classical Celiac Disease
15.2.2. Non-Classical Celiac Disease
15.2.3. Silent Celiac Disease
15.2.4. Potential celiac disease
15.2.5. Refractory celiac disease
15.2.5.1. Type I
15.2.5.2. Type
II
15.3. Middle East and Africa Celiac Disease
Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment Type
15.3.1. Gluten free diet
15.3.2. Vitamin and Mineral Supplements
15.3.3. Medical Therapies
15.4. Middle East and Africa Celiac Disease
Treatment Market Revenue (US$ Mn) and Forecasts, By Application
15.4.1. Children
15.4.2. Adults
15.5. Middle East and Africa Celiac Disease
Treatment Market Revenue (US$ Mn) and Forecasts, By End Users
15.5.1. Hospitals and Clinics
15.5.2. Research Centers
15.5.3. Others
15.6. Middle East and Africa Celiac Disease
Treatment Market Revenue (US$ Mn) and Forecasts, By Country
15.6.1. Saudi Arabia
15.6.1.1. Saudi Arabia Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By Celiac Disease Type
15.6.1.1.1. Classical Celiac Disease
15.6.1.1.2. Non-Classical Celiac Disease
15.6.1.1.3. Silent Celiac Disease
15.6.1.1.4. Potential celiac disease
15.6.1.1.5. Refractory celiac disease
15.6.1.1.5.1. Type I
15.6.1.1.5.2. Type
II
15.6.1.2. Saudi Arabia Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By Treatment Type
15.6.1.2.1. Gluten free diet
15.6.1.2.2. Vitamin and Mineral Supplements
15.6.1.2.3. Medical Therapies
15.6.1.3. Saudi Arabia Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By
Application
15.6.1.3.1. Children
15.6.1.3.2. Adults
15.6.1.4. Saudi Arabia Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By End Users
15.6.1.4.1. Hospitals and Clinics
15.6.1.4.2. Research Centers
15.6.1.4.3. Others
15.6.2. UAE
15.6.2.1. UAE Celiac Disease Treatment Market Revenue
(US$ Mn) and Forecasts, By Celiac Disease Type
15.6.2.1.1. Classical Celiac Disease
15.6.2.1.2. Non-Classical Celiac Disease
15.6.2.1.3. Silent Celiac Disease
15.6.2.1.4. Potential celiac disease
15.6.2.1.5. Refractory celiac disease
15.6.2.1.5.1. Type I
15.6.2.1.5.2. Type
II
15.6.2.2. UAE Celiac Disease Treatment Market Revenue
(US$ Mn) and Forecasts, By Treatment Type
15.6.2.2.1. Gluten free diet
15.6.2.2.2. Vitamin and Mineral Supplements
15.6.2.2.3. Medical Therapies
15.6.2.3. UAE Celiac Disease Treatment Market Revenue
(US$ Mn) and Forecasts, By Application
15.6.2.3.1. Children
15.6.2.3.2. Adults
15.6.2.4. UAE Celiac Disease Treatment Market Revenue
(US$ Mn) and Forecasts, By End Users
15.6.2.4.1. Hospitals and Clinics
15.6.2.4.2. Research Centers
15.6.2.4.3. Others
15.6.3. Egypt
15.6.3.1. Egypt Celiac Disease Treatment Market Revenue
(US$ Mn) and Forecasts, By Celiac Disease Type
15.6.3.1.1. Classical Celiac Disease
15.6.3.1.2. Non-Classical Celiac Disease
15.6.3.1.3. Silent Celiac Disease
15.6.3.1.4. Potential celiac disease
15.6.3.1.5. Refractory celiac disease
15.6.3.1.5.1. Type I
15.6.3.1.5.2. Type
II
15.6.3.2. Egypt Celiac Disease Treatment Market Revenue
(US$ Mn) and Forecasts, By Treatment Type
15.6.3.2.1. Gluten free diet
15.6.3.2.2. Vitamin and Mineral Supplements
15.6.3.2.3. Medical Therapies
15.6.3.3. Egypt Celiac Disease Treatment Market Revenue
(US$ Mn) and Forecasts, By Application
15.6.3.3.1. Children
15.6.3.3.2. Adults
15.6.3.4. Egypt Celiac Disease Treatment Market Revenue
(US$ Mn) and Forecasts, By End Users
15.6.3.4.1. Hospitals and Clinics
15.6.3.4.2. Research Centers
15.6.3.4.3. Others
15.6.4. Kuwait
15.6.4.1. Kuwait Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By Celiac Disease Type
15.6.4.1.1. Classical Celiac Disease
15.6.4.1.2. Non-Classical Celiac Disease
15.6.4.1.3. Silent Celiac Disease
15.6.4.1.4. Potential celiac disease
15.6.4.1.5. Refractory celiac disease
15.6.4.1.5.1. Type I
15.6.4.1.5.2. Type
II
15.6.4.2. Kuwait Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By Treatment Type
15.6.4.2.1. Gluten free diet
15.6.4.2.2. Vitamin and Mineral Supplements
15.6.4.2.3. Medical Therapies
15.6.4.3. Kuwait Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By
Application
15.6.4.3.1. Children
15.6.4.3.2. Adults
15.6.4.4. Kuwait Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By End Users
15.6.4.4.1. Hospitals and Clinics
15.6.4.4.2. Research Centers
15.6.4.4.3. Others
15.6.5. South Africa
15.6.5.1. South Africa Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By Celiac Disease Type
15.6.5.1.1. Classical Celiac Disease
15.6.5.1.2. Non-Classical Celiac Disease
15.6.5.1.3. Silent Celiac Disease
15.6.5.1.4. Potential celiac disease
15.6.5.1.5. Refractory celiac disease
15.6.5.1.5.1. Type I
15.6.5.1.5.2. Type
II
15.6.5.2. South Africa Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By Treatment Type
15.6.5.2.1. Gluten free diet
15.6.5.2.2. Vitamin and Mineral Supplements
15.6.5.2.3. Medical Therapies
15.6.5.3. South Africa Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By
Application
15.6.5.3.1. Children
15.6.5.3.2. Adults
15.6.5.4. South Africa Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By End Users
15.6.5.4.1. Hospitals and Clinics
15.6.5.4.2. Research Centers
15.6.5.4.3. Others
15.6.6. Rest of Middle East & Africa
15.6.6.1. Rest of Middle East & Africa Celiac
Disease Treatment Market Revenue (US$ Mn) and Forecasts, By Celiac Disease Type
15.6.6.1.1. Classical Celiac Disease
15.6.6.1.2. Non-Classical Celiac Disease
15.6.6.1.3. Silent Celiac Disease
15.6.6.1.4. Potential celiac disease
15.6.6.1.5. Refractory celiac disease
15.6.6.1.5.1. Type I
15.6.6.1.5.2. Type
II
15.6.6.2. Rest of Middle East & Africa Celiac
Disease Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment Type
15.6.6.2.1. Gluten free diet
15.6.6.2.2. Vitamin and Mineral Supplements
15.6.6.2.3. Medical Therapies
15.6.6.3. Rest of Middle East & Africa Celiac
Disease Treatment Market Revenue (US$ Mn) and Forecasts, By Application
15.6.6.3.1. Children
15.6.6.3.2. Adults
15.6.6.4. Rest of Middle East & Africa Celiac
Disease Treatment Market Revenue (US$ Mn) and Forecasts, By End Users
15.6.6.4.1. Hospitals and Clinics
15.6.6.4.2. Research Centers
15.6.6.4.3. Others
15.7. Key Segment for Channeling Investments
15.7.1. By Country
15.7.2. By Celiac Disease Type
15.7.3. By Treatment Type
15.7.4. By
Application
15.7.5. By End Users
16. Latin America Celiac Disease Treatment
Market Analysis and Forecasts, 2022 – 2030
16.1. Overview
16.1.1. Latin America Celiac Disease Treatment Market
Revenue (US$ Mn)
16.2. Latin America Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By Celiac Disease Type
16.2.1. Classical Celiac Disease
16.2.2. Non-Classical Celiac Disease
16.2.3. Silent Celiac Disease
16.2.4. Potential celiac disease
16.2.5. Refractory celiac disease
16.2.5.1. Type I
16.2.5.2. Type
II
16.3. Latin America Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By Treatment Type
16.3.1. Gluten free diet
16.3.2. Vitamin and Mineral Supplements
16.3.3. Medical Therapies
16.4. Latin America Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By
Application
16.4.1. Children
16.4.2. Adults
16.5. Latin America Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By End Users
16.5.1. Hospitals and Clinics
16.5.2. Research Centers
16.5.3. Others
16.6. Latin America Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By Country
16.6.1. Brazil
16.6.1.1. Brazil Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By Celiac Disease Type
16.6.1.1.1. Classical Celiac Disease
16.6.1.1.2. Non-Classical Celiac Disease
16.6.1.1.3. Silent Celiac Disease
16.6.1.1.4. Potential celiac disease
16.6.1.1.5. Refractory celiac disease
16.6.1.1.5.1. Type I
16.6.1.1.5.2. Type
II
16.6.1.2. Brazil Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By Treatment Type
16.6.1.2.1. Gluten free diet
16.6.1.2.2. Vitamin and Mineral Supplements
16.6.1.2.3. Medical Therapies
16.6.1.3. Brazil Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By
Application
16.6.1.3.1. Children
16.6.1.3.2. Adults
16.6.1.4. Brazil Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By End Users
16.6.1.4.1. Hospitals and Clinics
16.6.1.4.2. Research Centers
16.6.1.4.3. Others
16.6.2. Argentina
16.6.2.1. Argentina Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By Celiac Disease Type
16.6.2.1.1. Classical Celiac Disease
16.6.2.1.2. Non-Classical Celiac Disease
16.6.2.1.3. Silent Celiac Disease
16.6.2.1.4. Potential celiac disease
16.6.2.1.5. Refractory celiac disease
16.6.2.1.5.1. Type I
16.6.2.1.5.2. Type
II
16.6.2.2. Argentina Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By Treatment Type
16.6.2.2.1. Gluten free diet
16.6.2.2.2. Vitamin and Mineral Supplements
16.6.2.2.3. Medical Therapies
16.6.2.3. Argentina Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By
Application
16.6.2.3.1. Children
16.6.2.3.2. Adults
16.6.2.4. Argentina Celiac Disease Treatment Market
Revenue (US$ Mn) and Forecasts, By End Users
16.6.2.4.1. Hospitals and Clinics
16.6.2.4.2. Research Centers
16.6.2.4.3. Others
16.6.3. Rest of Latin America
16.6.3.1. Rest of Latin America Celiac Disease
Treatment Market Revenue (US$ Mn) and Forecasts, By Celiac Disease Type
16.6.3.1.1. Classical Celiac Disease
16.6.3.1.2. Non-Classical Celiac Disease
16.6.3.1.3. Silent Celiac Disease
16.6.3.1.4. Potential celiac disease
16.6.3.1.5. Refractory celiac disease
16.6.3.1.5.1. Type I
16.6.3.1.5.2. Type
II
16.6.3.2. Rest of Latin America Celiac Disease
Treatment Market Revenue (US$ Mn) and Forecasts, By Treatment Type
16.6.3.2.1. Gluten free diet
16.6.3.2.2. Vitamin and Mineral Supplements
16.6.3.2.3. Medical Therapies
16.6.3.3. Rest of Latin America Celiac Disease
Treatment Market Revenue (US$ Mn) and Forecasts, By Application
16.6.3.3.1. Children
16.6.3.3.2. Adults
16.6.3.4. Rest of Latin America Celiac Disease
Treatment Market Revenue (US$ Mn) and Forecasts, By End Users
16.6.3.4.1. Hospitals and Clinics
16.6.3.4.2. Research Centers
16.6.3.4.3. Others
16.7. Key Segment for Channeling Investments
16.7.1. By Country
16.7.2. By Celiac Disease Type
16.7.3. By Treatment Type
16.7.4. By
Application
16.7.5. By End Users
17. Competitive Benchmarking
17.1. Brand Benchmarking
17.2. Market Share Analysis, 2021
17.3. Global Presence and Growth Strategies
17.3.1. Mergers and Acquisitions
17.3.2. Product Launches
17.3.3. Investments Trends
17.3.4. R&D Initiatives
18. Player Profiles
18.1. 9 Meters Biopharma, Inc.
18.1.1. Company Details
18.1.2. Company Overview
18.1.3. Product Offerings
18.1.4. Key Developments
18.1.5. Financial Analysis
18.1.6. SWOT Analysis
18.1.7. Business Strategies
18.2. Adaptive Biotechnologies
18.2.1. Company Details
18.2.2. Company Overview
18.2.3. Product Offerings
18.2.4. Key Developments
18.2.5. Financial Analysis
18.2.6. SWOT Analysis
18.2.7. Business Strategies
18.3. Amgen Inc
18.3.1. Company Details
18.3.2. Company Overview
18.3.3. Product Offerings
18.3.4. Key Developments
18.3.5. Financial Analysis
18.3.6. SWOT Analysis
18.3.7. Business Strategies
18.4. AMYRA Biotech AG
18.4.1. Company Details
18.4.2. Company Overview
18.4.3. Product Offerings
18.4.4. Key Developments
18.4.5. Financial Analysis
18.4.6. SWOT Analysis
18.4.7. Business Strategies
18.5. BioLineRX Ltd.
18.5.1. Company Details
18.5.2. Company Overview
18.5.3. Product Offerings
18.5.4. Key Developments
18.5.5. Financial Analysis
18.5.6. SWOT Analysis
18.5.7. Business Strategies
18.6. Bioniz Theraputics.
18.6.1. Company Details
18.6.2. Company Overview
18.6.3. Product Offerings
18.6.4. Key Developments
18.6.5. Financial Analysis
18.6.6. SWOT Analysis
18.6.7. Business Strategies
18.7. Calypso Biotech
18.7.1. Company Details
18.7.2. Company Overview
18.7.3. Product Offerings
18.7.4. Key Developments
18.7.5. Financial Analysis
18.7.6. SWOT Analysis
18.7.7. Business Strategies
18.8. CeliAct
18.8.1. Company Details
18.8.2. Company Overview
18.8.3. Product Offerings
18.8.4. Key Developments
18.8.5. Financial Analysis
18.8.6. SWOT Analysis
18.8.7. Business Strategies
18.9. Gluten Free Therapeutics
18.9.1. Company Details
18.9.2. Company Overview
18.9.3. Product Offerings
18.9.4. Key Developments
18.9.5. Financial Analysis
18.9.6. SWOT Analysis
18.9.7. Business Strategies
18.10. ImmunogenX, Inc
18.10.1. Company Details
18.10.2. Company Overview
18.10.3. Product Offerings
18.10.4. Key Developments
18.10.5. Financial Analysis
18.10.6. SWOT Analysis
18.10.7. Business Strategies
18.11. Inovera
18.11.1. Company Details
18.11.2. Company Overview
18.11.3. Product Offerings
18.11.4. Key Developments
18.11.5. Financial Analysis
18.11.6. SWOT Analysis
18.11.7. Business Strategies
18.12. MOZART THERAPEUTICS
18.12.1. Company Details
18.12.2. Company Overview
18.12.3. Product Offerings
18.12.4. Key Developments
18.12.5. Financial Analysis
18.12.6. SWOT Analysis
18.12.7. Business Strategies
18.13. Precigen, Inc.
18.13.1. Company Details
18.13.2. Company Overview
18.13.3. Product Offerings
18.13.4. Key Developments
18.13.5. Financial Analysis
18.13.6. SWOT Analysis
18.13.7. Business Strategies
18.14. Takeda Pharmaceutical Company Limited
18.14.1. Company Details
18.14.2. Company Overview
18.14.3. Product Offerings
18.14.4. Key Developments
18.14.5. Financial Analysis
18.14.6. SWOT Analysis
18.14.7. Business Strategies
18.15. Vactech Oy
18.15.1. Company Details
18.15.2. Company Overview
18.15.3. Product Offerings
18.15.4. Key Developments
18.15.5. Financial Analysis
18.15.6. SWOT Analysis
18.15.7. Business Strategies
18.16. ZEDIRA GmbH
18.16.1. Company Details
18.16.2. Company Overview
18.16.3. Product Offerings
18.16.4. Key Developments
18.16.5. Financial Analysis
18.16.6. SWOT Analysis
18.16.7. Business Strategies
18.17. Other Market Participants
19. Key Findings
Note: This ToC is tentative and
can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
